Filing Flows › Utah Medical Products (UTMD) › Q2 2026 › vs Q1 2026
Utah Medical Products (UTMD) Q2 2026 vs Q1 2026 (quarter over quarter)
Utah Medical Products's revenue fell $193K (-2%) from $8.7M in Q1 2026 to $8.5M in Q2 2026. The biggest changes: Gynecology/Electrosurgery/Urology −$948K (-18%); Neonatal +$349K (+22%); Blood Pressure Monitoring and Accessories +$245K (+24%). Gross margin 55.8% against 60.6% (-4.8 pts).
Utah Medical Products, Q2 2026: revenue $8.5M (-14% year over year), operating margin 31.1%, net earnings $2.7M, operating cash flow $1.4M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 55.8% | 60.6% | -4.8 pts |
| Operating margin | 31.1% | 29.4% | +1.7 pts |
| Net margin | 31.5% | 29.9% | +1.6 pts |
| Free cash flow margin | 14.6% | 34.2% | -19.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Gynecology/Electrosurgery/Urology | $4.3M | $5.2M | −$948K | -18% |
| Neonatal | $1.9M | $1.6M | $349K | +22% |
| Blood Pressure Monitoring and Accessories | $1.3M | $1.0M | $245K | +24% |
| Obstetrics | $1.1M | $905K | $161K | +18% |
| Revenue | $8.5M | $8.7M | −$193K | -2% |
| Gross profit | $4.8M | $5.3M | −$524K | -10% |
| Cost of revenue | $3.8M | $3.4M | $331K | +10% |
| Other income, net | $637K | $617K | $20K | +3% |
| Operating profit | $2.6M | $2.6M | $84K | +3% |
| Operating expenses | $2.1M | $2.7M | −$608K | -22% |
| Pre-tax earnings | $3.3M | $3.2M | $104K | +3% |
| Research & development | $154K | $154K | $0 | 0% |
| SG&A | $2.0M | $2.6M | −$608K | -24% |
| Net earnings | $2.7M | $2.6M | $82K | +3% |
| Income tax | $600K | $578K | $22K | +4% |
| Depreciation & amortization | $226K | $673K | −$447K | -66% |
| Share-based compensation | $72K | $120K | −$48K | -40% |
| Working capital & other | $1.6M | $288K | $1.3M | +456% |
| Operating cash flow | $1.4M | $3.1M | −$1.7M | -56% |
| Free cash flow (OCF − capex) | $1.2M | $3.0M | −$1.7M | -58% |
| Capital expenditures | $134K | $130K | $4K | +3% |
Questions
How much did Utah Medical Products's revenue grow quarter over quarter in Q2 2026?
Utah Medical Products's revenue fell $193K (-2%) from $8.7M in Q1 2026 to $8.5M in Q2 2026.
What drove Utah Medical Products's revenue change in Q2 2026?
Gynecology/Electrosurgery/Urology −$948K (-18%); Neonatal +$349K (+22%); Blood Pressure Monitoring and Accessories +$245K (+24%).